Patent · US Active

Recombinant swine influenza virus and uses thereof

US10098944B2 · kind B2 · utility

0Cited by

10References

20Claims

0Family size

Assignee

University of Saskatchewan · CA

Inventors

Yan Zhou · Montville, US
Aleksandar Masic · Belleville, CA

Key dates

Filing date	Jul 25, 2016
Grant date	Oct 16, 2018
Priority date	—
Expiry date	Jul 25, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2799/025
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Recombinant, chimeric porcine influenza viruses are disclosed that include hemagglutinin segments from more than one influenza virus subtype. Also described are methods of producing the recombinant influenza viruses, immunogenic compositions comprising the recombinant influenza viruses, methods of stimulating an immune response against influenza virus, and methods of treating and preventing influenza virus infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.